Cargando…

Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment

BACKGROUND: Cerebral extracranial-intracranial (EC-IC) revascularization technique (superficial temporal artery-middle cerebral artery (STA-MCA) bypass grafting) has become the preferred surgical method for the treatment of Moyamoya disease (MMD). We attempted to completely free the two branches of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Liang, Huang, Yimin, Han, Yang, Li, Yu, Wan, Xueyan, Chen, Juan, Zhang, Xincheng, Shu, Kai, Lei, Ting, Wang, Sheng, Gan, Chao, Zhang, Huaqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628485/
https://www.ncbi.nlm.nih.gov/pubmed/37941571
http://dx.doi.org/10.3389/fneur.2023.1273822
_version_ 1785131769526222848
author Lu, Liang
Huang, Yimin
Han, Yang
Li, Yu
Wan, Xueyan
Chen, Juan
Zhang, Xincheng
Shu, Kai
Lei, Ting
Wang, Sheng
Gan, Chao
Zhang, Huaqiu
author_facet Lu, Liang
Huang, Yimin
Han, Yang
Li, Yu
Wan, Xueyan
Chen, Juan
Zhang, Xincheng
Shu, Kai
Lei, Ting
Wang, Sheng
Gan, Chao
Zhang, Huaqiu
author_sort Lu, Liang
collection PubMed
description BACKGROUND: Cerebral extracranial-intracranial (EC-IC) revascularization technique (superficial temporal artery-middle cerebral artery (STA-MCA) bypass grafting) has become the preferred surgical method for the treatment of Moyamoya disease (MMD). We attempted to completely free the two branches of the superficial temporal artery without disconnection. Extracranial and intracranial blood flow reconstruction were then modified by selectively performing a direct bypass technique on one branch and a patch fusion technique on the other of the STA based on the blood flow and the vascular diameter of the intracranial surface blood vessels. METHODS: A series of modified STA-MCA bypass surgeries performed consecutively between March 2022 and March 2023 were reviewed and compared to conventional combined bypass surgeries performed during the same period. The following information was collected from all enrolled patients: demographic characteristics, clinical symptoms, and preoperative and postoperative imaging, including Suzuki stage and Matsushima grade. The modified Rankin scale (mRS) was used to assess the changes in neurological status before and after surgery. RESULTS: A total of 41 patients with Moyamoya disease (MMD) who underwent cerebral revascularization were included in this study, of which 30 were conventional revascularization and 11 were modified revascularization. The mean age was 49.91 years, and 18 (43.9%) of the patients were women. The modified group had a lower incidence of cerebral hyperperfusion syndrome (18.2%) than the conventional group (23.3%). After at least 3 months of follow-up, the bypass patency rate remained 100% in the modified group and 93.3% in the conventional group. All patients in the modified group achieved a better Matsushima grade (A + B), with six (54.5%) having an A and five (45.5%) having a B. In contrast, four patients (13.3%) in the conventional group had a Matsushima grade of C. In all, 72.8% of the modified group had postoperative mRS scores of 0 and 1, which was higher than that of the traditional group (63.3%). CONCLUSION: The improved STA-MCA bypass could provide blood flow to multiple cerebral ischemic areas, reduce excessive blood perfusion, and ensure blood supply to the scalp, with lower complications and better clinical benefits than the traditional combined bypass.
format Online
Article
Text
id pubmed-10628485
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-106284852023-11-08 Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment Lu, Liang Huang, Yimin Han, Yang Li, Yu Wan, Xueyan Chen, Juan Zhang, Xincheng Shu, Kai Lei, Ting Wang, Sheng Gan, Chao Zhang, Huaqiu Front Neurol Neurology BACKGROUND: Cerebral extracranial-intracranial (EC-IC) revascularization technique (superficial temporal artery-middle cerebral artery (STA-MCA) bypass grafting) has become the preferred surgical method for the treatment of Moyamoya disease (MMD). We attempted to completely free the two branches of the superficial temporal artery without disconnection. Extracranial and intracranial blood flow reconstruction were then modified by selectively performing a direct bypass technique on one branch and a patch fusion technique on the other of the STA based on the blood flow and the vascular diameter of the intracranial surface blood vessels. METHODS: A series of modified STA-MCA bypass surgeries performed consecutively between March 2022 and March 2023 were reviewed and compared to conventional combined bypass surgeries performed during the same period. The following information was collected from all enrolled patients: demographic characteristics, clinical symptoms, and preoperative and postoperative imaging, including Suzuki stage and Matsushima grade. The modified Rankin scale (mRS) was used to assess the changes in neurological status before and after surgery. RESULTS: A total of 41 patients with Moyamoya disease (MMD) who underwent cerebral revascularization were included in this study, of which 30 were conventional revascularization and 11 were modified revascularization. The mean age was 49.91 years, and 18 (43.9%) of the patients were women. The modified group had a lower incidence of cerebral hyperperfusion syndrome (18.2%) than the conventional group (23.3%). After at least 3 months of follow-up, the bypass patency rate remained 100% in the modified group and 93.3% in the conventional group. All patients in the modified group achieved a better Matsushima grade (A + B), with six (54.5%) having an A and five (45.5%) having a B. In contrast, four patients (13.3%) in the conventional group had a Matsushima grade of C. In all, 72.8% of the modified group had postoperative mRS scores of 0 and 1, which was higher than that of the traditional group (63.3%). CONCLUSION: The improved STA-MCA bypass could provide blood flow to multiple cerebral ischemic areas, reduce excessive blood perfusion, and ensure blood supply to the scalp, with lower complications and better clinical benefits than the traditional combined bypass. Frontiers Media S.A. 2023-10-24 /pmc/articles/PMC10628485/ /pubmed/37941571 http://dx.doi.org/10.3389/fneur.2023.1273822 Text en Copyright © 2023 Lu, Huang, Han, Li, Wan, Chen, Zhang, Shu, Lei, Wang, Gan and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Lu, Liang
Huang, Yimin
Han, Yang
Li, Yu
Wan, Xueyan
Chen, Juan
Zhang, Xincheng
Shu, Kai
Lei, Ting
Wang, Sheng
Gan, Chao
Zhang, Huaqiu
Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment
title Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment
title_full Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment
title_fullStr Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment
title_full_unstemmed Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment
title_short Clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in Moyamoya disease treatment
title_sort clinical effect of a modified superficial temporal artery-middle cerebral artery bypass surgery in moyamoya disease treatment
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628485/
https://www.ncbi.nlm.nih.gov/pubmed/37941571
http://dx.doi.org/10.3389/fneur.2023.1273822
work_keys_str_mv AT luliang clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT huangyimin clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT hanyang clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT liyu clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT wanxueyan clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT chenjuan clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT zhangxincheng clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT shukai clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT leiting clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT wangsheng clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT ganchao clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment
AT zhanghuaqiu clinicaleffectofamodifiedsuperficialtemporalarterymiddlecerebralarterybypasssurgeryinmoyamoyadiseasetreatment